InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,995.82
(
-0.31%
)
US TECH 100
16,840.00
(
-0.57%
)
Dow Jones
37,916.71
(
0.37%
)
Brent Oil
86.81
(
0.46%
)
Bitcoin
64,484.71
(
1.53%
)
Post# of 1522
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

madrose1

Send PM Follow Ignore
Followers 283
Posts 47139
Boards Moderated 10
Alias Born 04/07/2001

madrose1

Member Level

Re: madrose1 post# 1511

Friday, 06/01/2007 4:34:27 AM

Friday, June 01, 2007 4:34:27 AM

Post# of 1522
Sepracor to shine-BusinessWeek
From the "Inside Wall Street" section: Sentiment is divided on Wall Street regarding Sepracor (SEPR), best known for its sleep drug, Lunesta. BMO Capital Market's Robert Hazlett says the gloom and doom is overdone regarding SEPR, he thinks the stock will hit $68 in 12-18 months, and argues that the company is going to be more profitable than analysts estimate.

Know how to make God laugh?
Tell Her your plans ....

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up